Masuda D, Nohara R, Inada H, Hirai T, Li-Guang C, Kanda H, Inubushi M, Tadamura E, Fujita M, Sasayama S
Department of Cardiovascular Medicine, Kyoto University, Graduate School of Medicine, Japan.
Jpn Circ J. 1999 May;63(5):407-11. doi: 10.1253/jcj.63.407.
Enhanced external counterpulsation (EECP) is a noninvasive treatment for chronic stable angina, which works by recruiting and developing the coronary collateral vessels. Coronary perfusion and coronary flow reserve (CFR) were evaluated by nitrogen-13 (13N) ammonia positron emission tomography (PET) in a patient who had undergone EECP. The patient, who had 3-vessel coronary artery disease, required a percutaneous transluminal coronary angioplasty (PTCA) for the right coronary artery. The PTCA was successful, but 6 months later he again felt chest oppression. The coronary angiography showed re-stenosis at the PTCA site, and other progressive coronary stenosis. The patient was again treated with EECP for 35 h. The 13N-ammonia PET was performed both at baseline and during dipyridamole provocation, before and after EECP treatment. Coronary perfusion of each myocardial wall increased at the baseline (anterior: 0.52-0.75; septal: 0.48-0.66; lateral: 0.61-0.68; inferior: 0.46-0.57 ml min(-1) g(-1), and the CFRs in the septal and inferior walls (septal: 2.07-2.15; inferior: 1.99-2.06) also increased after the treatment. Thus, the EECP treatment improved both coronary perfusion at baseline and CFR, which suggests that it may be one of the choices for treatment of angina.
增强型体外反搏(EECP)是一种用于治疗慢性稳定型心绞痛的非侵入性疗法,其作用机制是促使冠状动脉侧支血管生成与发展。采用氮 - 13(¹³N)氨正电子发射断层扫描(PET)对一名接受过EECP治疗的患者进行冠状动脉灌注及冠状动脉血流储备(CFR)评估。该患者患有三支冠状动脉疾病,右冠状动脉需要行经皮冠状动脉腔内血管成形术(PTCA)。PTCA手术成功,但6个月后他再次感到胸部憋闷。冠状动脉造影显示PTCA部位出现再狭窄以及其他冠状动脉渐进性狭窄。该患者再次接受35小时的EECP治疗。在EECP治疗前后,分别于基线状态及双嘧达莫激发试验期间进行¹³N - 氨PET检查。治疗前,各心肌壁的冠状动脉灌注情况为:前壁0.52 - 0.75;间隔0.48 - 0.66;侧壁0.61 - 0.68;下壁0.46 - 0.57 ml·min⁻¹·g⁻¹,治疗后间隔壁和下壁的CFR(间隔壁:2.07 - 2.15;下壁:1.99 - 2.06)也有所增加。因此,EECP治疗可改善基线状态下的冠状动脉灌注及CFR,这表明它可能是治疗心绞痛的选择之一。